The immunopathological spectrum of crescentic glomerulonephritis: A survey of 106 patients in a single Chinese center

Nephron - Clinical Practice

Volumn 116, Issue 1, 2010, Pages

  Lin, Wei ^a   Chen, Min ^a   Cui, Zhao ^a   Zhao, Ming Hui ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Anti glomerular basement membrane; Antineutrophil cytoplasmic antibodies; Crescentic glomerulonephritis; Immunofluorescence

Indexed keywords

IMMUNOGLOBULIN; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CRESCENTIC GLOMERULONEPHRITIS; DISEASE CLASSIFICATION; FEMALE; GLOMERULONEPHRITIS; GLOMERULUS BASEMENT MEMBRANE; HEALTH SURVEY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOPATHOLOGY; KIDNEY NECROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; AUTOANTIBODIES; BASEMENT MEMBRANE; BIOLOGICAL MARKERS; CHINA; DATA COLLECTION; FEMALE; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 77952507248     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000314665     Document Type: Article

References (37)

1. Pettersson EE, Sundelin B, Heigl Z: Incidence and outcome of pauci-immune necrotizing and crescentic glomerulonephritis in adults. Clin Nephrol 1995; 43: 141-149.
2. Panichi V, Pasquariello A, Innocenti M, et al: The Pisa experience of renal biopsies, 1977- 2005. J Nephrol 2007; 20: 329-335.
3. Levy JB, Turner AN, Rees AJ, Pusey CD: Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma-exchange and immunosuppression. Ann Intern Med 2001; 134: 1033-1042.
4. Jennette JC: Rapidly progressive crescentic glomerulonephritis. Kidney Int 2003; 63: 1164-1177.
5. Rutgers A, Slot M, van Paassen P, van Breda Vriesman P, Heeringa P, Tervaert JW: Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis. Am J Kidney Dis 2005; 46: 253-262.
6. Savage COS: ANCA-associated renal vasculitis. Kidney Int 2001; 60: 1614-1627.
7. Hellmark T, Niles JL, Collins AB, McCluskey RT, Brunmark C: Comparison of anti-GBM antibodies in sera with or without ANCA. J Am Soc Nephrol 1997; 8: 376-385.
8. Levy JB, Hammad T, Coulthart A, Dougan T, Pusey CD: Clinical features and outcome of patients with both ANCA and anti-GBM antibodies. Kidney Int 2004; 66: 1535-1540.
9. Zhao J, Yang R, Cui Z, Chen M, Zhao MH, Wang HY: Characteristics and outcome of Chinese patients with both antineutrophil cytoplasmic antibody and antiglomerular basement membrane antibodies. Nephron Clin Pract 2007; 107:c56-c62.
10. Yu F, Chen M, Wang SX, Zou WZ, Zhao MH, Wang HY: Clinical and pathological characteristics and outcomes of Chinese patients with primary anti-neutrophil cytoplasmic antibodies-associated systemic vasculitis with immune complex deposition in kidney. Nephrology (Carlton) 2007; 12: 74-80.
11. Haas M, Eustace JA: Immune complex deposits in ANCA-associated crescentic glomerulonephritis: a study of 126 cases. Kidney Int 2004; 65: 2145-2152.
12. Neumann I, Regele H, Kain R, Birck R, Meisl FT: Glomerular immune deposits are associated with increased proteinuria in patients with ANCA-associated crescentic nephritis. Nephrol Dial Transplant 2003; 18: 524-531.
13. Chen M, Kallenberg CG, Zhao MH: ANCAnegative pauci-immune crescentic glomerulonephritis. Nat Rev Nephrol 2009; 5: 313-318.
14. Chen M, Yu F, Wang SX, Zou WZ, Zhao MH, Wang HY: Antineutrophil cytoplasmic autoantibody- negative pauci-immune crescentic glomerulonephritis. J Am Soc Nephrol 2007; 18: 599-605.
15. Harris AA, Falk RJ, Jennette JC: Crescentic glomerulonephritis with a paucity of glomerular immunoglobulin localization. Am J Kidney Dis 1998; 32: 179-184.
16. Falk RJ, Jennette JC, Nachman PH: Primary glomerular disease; in Brenner BM (ed): The Kidney, ed 7. Philadelphia, Saunders, 2004, pp 1293-1380.
17. Jennette JC, Falk RJ: The pathology of vasculitis involving the kidney. Am J Kidney Dis 1994; 24: 130-141.
18. Zhao MH, Lockwood CM: A comprehensive method to purify three major ANCA antigens: proteinase 3, myeloperoxidase and bactericidal/ permeability- increasing protein from human neutrophil granule acid extract. J Immunol Methods 1996; 197: 121-130.
19. Cui Z, Zhao MH, Xin G, Wang HY: Characteristics and prognosis of Chinese patients with anti-glomerular basement membrane disease. Nephron Clin Pract 2005; 99:c49-c55.
20. Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, Xu JS, Huang SM, Wang LN, Huang W, Wang M, Xu GB, Wang HY: Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 2006; 17: 2937-2944.
21. Zhao MH, Yu J, Liu YC, Zou WZ, Zhang YK, Wang HY: Immunopathological classification and clinicopathological analysis of 100 patients with crescentic glomerulonephritis. Chin J Nephrol 2001; 17: 294-297.
22. Tang Z, Yao X, Hu W, Zeng C, Chen H, Liu Z, Li L: The clinical and pathological characteristics of Chinese patients with pauci-immune crescent glomerulonephritis. Chin Med J (Engl) 2001; 114: 374-378.
23. Liu G, Ma XZ, Zou WZ, Wang M, Wang HY: The prevalence of biopsy-proven renal diseases in adults between two periods over the past 10 years. J Clin Intern Med 2004; 12: 834-838.
24. Tang Z, Wu Y, Wang QW, Yu YS, Hu WX, Yao XD, Chen HP, Liu ZH, Li LS: Idiopathic IgA nephropathy with diffuse crescent formation. Am J Nephrol 2002; 22: 480-486.
25. Harris AA, Falk RJ, Jennette JC: Crescentic glomerulonephritis with a paucity of glomerular immunoglobulin localization. Am J Kidney Dis 1998; 32: 179-184.
26. Jennette JC, Wilkman AS, Falk RJ: Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis. Am J Pathol 1989; 135: 921-930.
27. Falk RJ, Jennette JC: ANCA small-vessel vasculitis. J Am Soc Nephrol 1997; 8: 314-322.
28. Xiao H, Heeringa P, Hu P, Liu Z, Zhao M, Aratani Y, Maeda N, Falk RJ, Jennette JC: Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 2002; 110: 955-963.
29. Brouwer E, Huitema MG, Klok PA, de Weerd H, Tervaert JW, Weening JJ, Kallenberg CG: Antimyeloperoxidase-associated proliferative glomerulonephritis: an animal model. J Exp Med 1993; 177: 905-914.
30. Brons RH, de Jong MC, de Boer NK, Stegeman CA, Kallenberg CG, Cohen Tervaert JW: Detection of immune deposits in skin lesions of patients with Wegener's granulomatosis. Ann Rheum Dis 2001; 60: 1097-1102.
31. Lerner RA, Glassock RJ, Dixon FJ: The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J Am Soc Nephrol 1999; 10: 1389-1404.
32. Kluth DC, Rees AJ: Anti-glomerular basement membrane disease. J Am Soc Nephrol 1999; 10: 2446-2453.
33. Nayak SG, Satish R: Crescentic transformation in primary membranous glomerulopathy: association with anti-GBM antibody. Saudi J Kidney Dis Transpl 2007; 18: 599-602.
34. Kielstein JT, Helmchen U, Netzer KO, Weber M, Haller H, Floege J: Conversion of Goodpasture's syndrome into membranous glomerulonephritis. Nephrol Dial Transplant 2001; 16: 2082-2085.
35. Sano T, Kamata K, Shigematsu H, Kobayashi Y: A case of anti-glomerular basement membrane glomerulonephritis superimposed on membranous nephropathy. Nephrol Dial Transplant 2000; 15: 1238-1241.
36. Hall AM, Symington EM, Sampson SA, Kwan JT: Crescentic transformation of membranous glomerulopathy: a reversible condition. Nephrol Dial Transplant 2006; 21: 1136-1137.
37. Cui Z, Zhao MH, Wang SX, Liu G, Zou WZ, Wang HY: Concurrent antiglomerular basement membrane disease and immune complex glomerulonephritis. Ren Fail 2006; 28: 7-14.